Patents by Inventor Michel Dard
Michel Dard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11331167Abstract: Two part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.Type: GrantFiled: December 18, 2018Date of Patent: May 17, 2022Assignee: STRAUMANN HOLDING AGInventors: Frank Schwarz, Jürgen Becker, Marco Wieland, Michel Dard
-
Publication number: 20190117344Abstract: Two part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.Type: ApplicationFiled: December 18, 2018Publication date: April 25, 2019Applicant: STRAUMANN HOLDING AGInventors: Frank SCHWARZ, Jürgen BECKER, Marco WIELAND, Michel DARD
-
Publication number: 20150086943Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.Type: ApplicationFiled: September 2, 2014Publication date: March 26, 2015Applicant: STRAUMANN HOLDING AGInventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
-
Publication number: 20130196289Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.Type: ApplicationFiled: January 31, 2013Publication date: August 1, 2013Applicant: Straumann Holding AGInventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
-
Publication number: 20110312891Abstract: Isolated active compound of a naturally occurring fraction of Enamel Matrix Derivatives (EMD), having at least one of each two N-terminal polypeptide fragments of amelogenin, which are at least 95% identical to an amino acid sequence as shown in SEQ. ID. No:1 and/or 2. The invention relates to the use of said isolated active compound of a fraction and/or of the fraction itself, and/or the at least one of each two polypeptide fragments for use as a medicament and/or for the manufacture of a pharmaceutical composition for a variety of different medical indications such as inducing and/or promoting cementogenesis, bone growth and/or binding between parts of living mineralised tissue, for bonding of a piece of living mineralised tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, for inducing regeneration of dentin, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.Type: ApplicationFiled: June 29, 2009Publication date: December 22, 2011Applicant: Straumann Holding AGInventors: Stina Gestrelius, Michel Dard, Ruzica Ranevski, S. Petter Lyngstadaas, Corinna Mauth
-
Patent number: 8029283Abstract: Abutment of a dental implant system, having at the top a support region intended for receiving a prosthetic build-up construction and at the bottom an implant contact region intended for insertion into a receiving hole of an implant, and wherein the abutment has between the support region and the implant contact region a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated.Type: GrantFiled: February 28, 2007Date of Patent: October 4, 2011Assignee: Straumann Holding AGInventors: Frank Schwarz, Jürgen Becker, Marco Wieland, Michel Dard
-
Patent number: 7655624Abstract: The invention relates to compounds of formula (1) B-Q-X1, wherein B is bioactive cell adhesive mediating molecule. Q is absent or is an inorganic spacer molecule and X1 is an anchor molecule, selected from the group Lys-(CO—CH2—(CH2)n—PO3H2)2(I), -Lys-[-Lys-(CO—CH2—(CH2)a—PO3H2)2]2(ii) or -Lys-(Lys[-Lys-(CO—CH2—(CH2)n—PO3H2]2 (iii), and n independently represents 0, 1, 2 or 3, wherein a free amino group of group B is linked in peptide form to a free carboxyl group of the spacer molecule Q or of the anchor molecule X1, or a free amino group of the radical Q is linked in peptide form to a free carboxyl group of the radical X1. The invention also relates to the salts thereof.Type: GrantFiled: August 2, 2001Date of Patent: February 2, 2010Assignee: Biomet Deutschland GmbHInventors: Joerg Meyer, Berthold Nies, Michel Dard, Guenter Hoelzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
-
Patent number: 7276482Abstract: The invention relates to compounds of formula (I) B-Q-X1, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 1) (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 2) (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 3) (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (SEQ ID NO: 4) (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (SEQ ID NO: 5) (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (SEQ ID NO: 6) (vii), wherein (i) X, Y, Z, R2, R3, R4, A, Ar, Hal, Het, Het1, n, m, o, p, q, s, t have the meanings cited in claim 1, Q is absent or is an organic spacer molecule, X1 is an anchor molecule selected from the group cited in claim 1, and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illness, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to thType: GrantFiled: August 2, 2001Date of Patent: October 2, 2007Assignee: Biomet Deutschland GmbHInventors: Joerg Meyer, Berthold Nies, Michel Dard, Guenter Hoelzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
-
Publication number: 20070202462Abstract: Abutment of a dental implant system, having at the top a support region intended for receiving a prosthetic build-up construction and at the bottom an implant contact region intended for insertion into a receiving hole of an implant, and wherein the abutment has between the support region and the implant contact region a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated.Type: ApplicationFiled: February 28, 2007Publication date: August 30, 2007Applicant: Straumann Holding AGInventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
-
Publication number: 20070202464Abstract: One-part implant for attachment of artificial teeth comprising an anchoring part and a mounting part, wherein the anchoring part and the mounting part are configured in one piece. The anchoring part of the one-part implant has a bone contact surface B and a soft tissue contact surface S. The soft tissue contact surface S is at least partially hydroxylated or silanated, which results in an improved soft tissue integration.Type: ApplicationFiled: February 28, 2007Publication date: August 30, 2007Applicant: Straumann Holding AGInventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
-
Publication number: 20070202466Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.Type: ApplicationFiled: February 28, 2007Publication date: August 30, 2007Applicant: Straumann Holding AGInventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
-
Patent number: 7229545Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.Type: GrantFiled: April 16, 2003Date of Patent: June 12, 2007Assignee: Biomet Deutschland GmbHInventors: Andreas Sewing, Michel Dard, Sophie Roessler, Dieter Scharnweber, Hartmut Worch
-
Publication number: 20040043937Abstract: The invention relates to compounds of formula (I) B-Q-X1, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (vii), wherein (i) X, Y, Z, R2, R3, R4, A, Ar, Hal, Het, Het1, n, m, o, p, q, s, t have the meanings cited in claim 1, Q is absent or is an organic spacer molecule, X1 is an anchor molecule selected from the group cited in claim 1, and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illness, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to the acceleration and strengthening of the integration process of implants or the biocompatibType: ApplicationFiled: February 14, 2003Publication date: March 4, 2004Inventors: Jorg Meyer, Berthold Nies, Michel Dard, Gunter Holzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
-
Publication number: 20040033249Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.Type: ApplicationFiled: April 16, 2003Publication date: February 19, 2004Applicant: Merck Patent Gesellschaft mit Beschrankter HaftungInventors: Andreas Sewing, Michel Dard, Sophie Roessler, Dieter Scharnweber, Hartmut Worch
-
Publication number: 20040029782Abstract: The invention relates to compounds of formula (1) I-Q-X1, wherein B is bioactive cell adhesive mediating molecule. Q is absent or is an inorganic spacer molecule and X1 is an anchor molecule, selected from the group Lys.(CO—CH —(CH2)n—PO3H2)2(I)-Lys[-Lys-(CO—CH2—(CH2)a—PO3H2)2]2(ii) or -Lys-(Lys[-Lys-(CO—CH2—(CH2)n—PO3H2]2 (iii), and n independently represents 0, 1, 2 or 3, wherein a free amino group of group B is linked in peptide form to a free carboxyl group of the spacer molecule Q or of the anchor molecule X1 or a free amino group of the radical Q is linked in peptide form to a free carboxyl group of the radical X1. The invention also relates to the salts thereof.Type: ApplicationFiled: February 14, 2003Publication date: February 12, 2004Inventors: J?ouml;rg Meyer, Berthold Nies, Michel Dard, Gunter Holzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
-
Publication number: 20020018798Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.Type: ApplicationFiled: June 21, 2001Publication date: February 14, 2002Applicant: Merck Patent Gesellschaft mit Beschrankter HaftungInventors: Andreas Sewing, Michel Dard, Sophie Rossler, Dieter Scharnweber, Hartmut Worch
-
Patent number: 5762499Abstract: A dental root implant has a metal implant body which has transverse openings near its rounded lower end. The implant body has a shape which tapers downwards. Circumferential grooves are arranged parallel and mutually separated in its outer face, the grooves being rounded at their bases and at the junctions with neighboring outer face sections.Type: GrantFiled: June 21, 1996Date of Patent: June 9, 1998Assignee: Merck Patent Gesellschaft mit beschrankter HaftungInventors: Michel Dard, Gerard De Witte, Philippe Rouvre